Treatment of chemotherapy induced febrile neutropenia in patients with lung and pleural tumours with ertapenem Source: Eur Respir J 2004; 24: Suppl. 48, 73s Year: 2004
Antibiotic prophylaxis in chemotherapy-induced neutropenia in lung cancer patients Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients Year: 2011
The effectiveness of pegfilgrastim in preventing leucopenia in patients with lung cancer under chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 77s Year: 2005
The incidence of neutropenia in patients undergoing outpatient chemotherapy for lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 755s Year: 2006
Lung cancer patients hospitalized for febrile neutropenia: A retrospective study Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010
Neutropenia in lung cancer cases after chemotherapy Source: Eur Respir J 2006; 28: Suppl. 50, 753s Year: 2006
Pegfilgrastim drastically lowered risk of febrile neutropenia in Japanese patients with thoracic malignancy receiving chemotherapy - a retrospective single institutional study Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018
Management of chemotherapy-induced anemia in patients with lung cancer (LC): A comparative study of erythropoietic agents Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012
Role of flexible bronchoscopy in the management of patients with febrile neutropenia and lung infiltrates in a cancer setting hospital Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019
Risk factors of febrile neutropenia induced by chemotherapy in lung cancer patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016
Chemotherapy induced neutropenia in lung cancer patients: a single centre study Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009
Significance of febrile episode in patients with lung cancer during therapy - comparison of NSCLC and SCLC patients Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002
Prognosis of acute respiratory distress syndrome in neutropenic cancer patients Source: Eur Respir J 2012; 40: 169-176 Year: 2012
The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia Source: Eur Respir J 2009; 33: 142-147 Year: 2009
The effect of smoking on chemotherapy related nausea and vomiting in cancer patients Source: Annual Congress 2008 - Tobacco smoking by population subgroups Year: 2008
Predictive role of MMP-2 genetic variants on severe hematologic toxicity of NSCLC patients treated with first-line, platinum-based chemotherapy Source: Annual Congress 2011 - Genetics of airway diseases and treatment Year: 2011
Clinical characteristic of lung cancer patients with interstitial pneumonia treated with chemotherapy or radiotherapy Source: Annual Congress 2008 - Therapy of thoracic tumours Year: 2008
Efficacy of darbepoietin alfa in anemia developed during chemotherapy for lung cancer Source: Annual Congress 2008 - Treatment of thoracic tumours Year: 2008
The prognostic value of anemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011